Under construction – not a live service
Sign in
Not yet taking people in PortugalNo phase

Grouping heart failure patients by clinical data and exercise test responses

Reviews past records of adults with heart failure to find patient subgroups.

Key facts

Who runs it
Instituto Politécnico de Leiria
Where
Leiria, PortugalSee the 2 sites
Trial code
Registry title
Data-Driven Phenotyping in Heart Failure With Preserved Ejection Fraction
Status
Not yet recruiting
People taking part
200 people, planned
Starts
1 Dec 2026
Expected to end
31 May 2028
Type of study
Observational
Record updated
24 February 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with heart failure with preserved ejection fraction (HFpEF). First, past records are reviewed; a smaller group then does one exercise test visit.

Age
18 years or older
Sex
All sexes can join
Disease stage
Established diagnosis of heart failure with preserved ejection fraction (LVEF ≥50%).

Main reasons for not taking part

  • Incomplete or inadequate medical records (records review phase)
  • Medical reason or physical inability that prevents the exercise test (CPET)
  • Cannot give informed consent (exercise test phase)

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Retropective observational phase (Phase I):; Age ≥18 years; Established diagnosis of heart failure with preserved ejection fraction (LVEF ≥50%); Patients receiving care (outpatient or inpatient) at the Local Health Unit of the Leiria Region (ULS RL) since September 2018
  • Cross-sectional observational phase (Phase II - CPET):; Age ≥18 years; Established diagnosis of HFpEF; Selection as a volunteer representative of phenotypes identified in the retrospective clustering analysis; Provision of written informed consent prior to any study-specific procedures

Who cannot take part

  • Retropective observational phase (Phase I):; Incomplete or inadequate medical records preventing full data extraction
  • Cross-sectional observational phase (Phase II - CPET):; Medical contraindication or physical inability to perform cardiopulmonary exercise testing (CPET); Inability to provide informed consent

Where in Portugal

  • ciTechCare - Center for Innovative Care and Health TechnologyLeiria, PortugalContact: Maria P S Guarino, PhDNo longer taking part
  • Local Health Unit of the Leiria RegionLeiria, PortugalContact: Cristiana FernandesNo longer taking part

About the trial

What the trial wants to find out

The goal of this observational study is to learn how people with Heart Failure with Preserved Ejection Fraction (HFpEF) can be grouped into different "phenotypes" based on their clinical information. The researchers want to understand whether these groups have different health profiles and different responses during a cardiopulmonary exercise test (CPET).

Read full original descriptionShow less

The main questions this study aims to answer are:

* Can clinical data be used to identify meaningful HFpEF phenotypes? * Do these phenotypes match well-known HFpEF scores, such as the H2FPEF and Heart Failure Association Pre-test Assessment, Echocardiography and Natriuretic Peptide (HFA-PEFF) scores? * Do people in different phenotypes show different results on a CPET?

Participants will:

* Have their past clinical records reviewed if they were diagnosed with HFpEF at the Local Health Unit of the Leiria Region (ULS RL); * A smaller group will attend one visit to complete a CPET, which measures how the heart, lungs and muscles respond during exercise.

This study includes adults aged 18 years or older who have HFpEF. The study does not involve any new treatments or experimental drugs.

The group in the trial

  • Observational HFpEF Cohort

    Single observational cohort including all adults with an established diagnosis of heart failure with preserved ejection fraction (LVEF ≥50%) who received care at the Local Health Unit of the Leiria Region (ULS RL) since September 2018. Clinical, biochemical, imaging, functional, and therapeutic information recorded during previous hospitalizations will be extracted for retrospective analysis. A subset of participants will later be invited to complete a single cardiopulmonary exercise test (CPET) according to the study protocol. Phenotypes (clusters) will be identified post-hoc using unsupervised machine-learning methods and are not predefined at the time of enrollment.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Data-Driven Phenotyping in Heart Failure With Preserved Ejection Fraction
Plain-language title
Grouping heart failure patients by clinical data and exercise test responsesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Record updated
24 February 2026